NEW YORK (GenomeWeb) – Proteomics-based diagnostics firm Provista Diagnostics has raised $3.9 million, it said in a regulatory document filed on Monday. 

The Scottsdale, Ariz.-based firm did not respond to requests for comment. In a document filed with the US Securities and Exchange Commission, Provista said that there were 24 investors in the private offering of equity. It did not say how the funds would be used. 

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

A new report highlights the potential threats posed by advances in synthetic biology, NPR reports.

A Bloomberg reporter tried to get her genetic data deleted, but found it's not so simple to do.

Johns Hopkins University's Steven Salzberg and his colleagues have come up with a new estimate for the number of human genes, Nature News reports.

In Genome Research this week: study of intra-tumor heterogeneity, workflow resources for EPIGEN-Brazil, and more.